Joint%20Meeting%20of%20CMO%20and%20AMR-NFP%20Discussion%20and%20Conclusions

1
Joint Meeting of CMO and AMR-NFPDiscussion and
Conclusions
Marija Seljak, Director General of Public
Health Ministry of Health
2

• Antimicrobial resistance remains one of the
  serious European and global health problem
• In most MS between 2001 and 2005 an increase of
  the burden of antimicrobial resistance can be
  observed (EARSS)

3

• marked differences in AB use between EU countries
  and in the types of AB that are used
• consistent association between the level of use
  of certain AB and resistance to these AB has been
  reported confirming the suspected relationship
  between AB use and AMR in EU countries

4

• Recommendations on prudent use of antimicrobials
  in human medicine adopted in 2001
• MS, European Commission and EU agencies (ECDC,
  EFSA, EMEA,) have taken variety of actions

5

• What are the areas of the Recommendations where
  the actions need to be improved?

6
Need for

• developing national strategy with translation to
  action plan
• ensuring ownership at the local level

7
Need for

• Setting up inter-sectorial mechanism, e.g. a
  national committee, involving all relevant
  stakeholders with the clear mandate and political
  support

8
Need for

• Strengthening surveillance systems and data
  quality on antimicrobial resistance, use of
  antimicrobial agents and healthcare-associated
  infections

9
Need for

• Promoting good hygiene practices for the control
  of the transmission multidrug resistance bacteria

10
Need for

• Promoting prudent use of antibiotics through
  awareness campaigns with credible, scientifically
  based messages and actions, aimed at the
  practitioners and general public and include
  information about the risk of self-medication

11
Need for at EU level

• Follow up on the implementation of Council
  Recommendations
• Continue with Health in all policies approach
  in this area through EU initiatives

12
Need for at EU level

• Continue with activities within the ECDC in this
  area (country visits, recommendations, scientific
  work, surveillance)
• Exchange of best practices among MS
• Antibiotic Awareness Day

13
HVALA! THANK YOU!